← Browse by Condition
Medical Condition

treatment na ve mantle cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05051891 Phase 3
Recruiting

A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

Enrollment
356 pts
Location
China
Sponsor
Beijing InnoCare Pharma Tech C...
View Trial →